Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Schedule 13D — Beneficial ownership over 5% (may seek to influence the company)All the details
5 insiders in a week, a first since 2020Traded Nov 9 · filed 3 days later
A major shareholder of Orchestra Biomed paid $6M out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 19 months.
5 insiders in a week, a first since 2020Traded Nov 9 · filed the same day
The CFO of Orchestra Biomed paid $5K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 15 months.
5 insiders in a week, a first since 2020Traded Nov 9 · filed the same day
An Orchestra Biomed director paid $25K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.